Kinsenoside prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis by regulating classical NF-κB pathways

Documenti analoghi

• Amlexanox Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss
  di: Zhang, Yong, et al.
  Pubblicazione: (2015)
• Fermented Oyster Extract Prevents Ovariectomy-Induced Bone Loss and Suppresses Osteoclastogenesis
  di: Ihn, Hye Jung, et al.
  Pubblicazione: (2019)
• Inhibition of PFKFB3 suppresses osteoclastogenesis and prevents ovariectomy‐induced bone loss
  di: Wang, Jia, et al.
  Pubblicazione: (2019)
• KMUP-1 Suppresses RANKL-Induced Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss: Roles of MAPKs, Akt, NF-κB and Calcium/Calcineurin/NFATc1 Pathways
  di: Liou, Shu-Fen, et al.
  Pubblicazione: (2013)
• (−)-Epicatechin 3-O-β-d-allopyranoside prevent ovariectomy-induced bone loss in mice by suppressing RANKL-induced NF-κB and NFATc-1 signaling pathways
  di: Hsiao, Hung-Bo, et al.
  Pubblicazione: (2017)